Barriers to Pre-Exposure Prophylaxis (PrEP) Use for HIV: an Integrative Review

Overview

Journal Rev Bras Enferm

Specialty Nursing

Date 2023 Jun 28

PMID 37377313

Authors

Marcela Antonini

Ingred Evangelista da Silva

Henrique Ciabotti Elias

Larissa Gerin

Aliete Cunha Oliveira

Renata Karina Reis

Affiliations

Soon will be listed here.

Abstract

Objectives: to identify and synthesize scientific evidence on the barriers and difficulties for Pre-exposure Prophylaxis (PrEP) use and compliance for HIV.

Methods: an integrative literature review, using the MEDLINE/PubMed, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Academic Search Premier and Scopus (Elsevier) databases.

Results: all (100%) the articles included identified that PrEP users experience some type of structural barrier related to health services such as long distance from the units, suboptimal logistics for taking pills and professional resistance to prescribing PrEP. Furthermore, 63.21% identified social barriers, such as stigma about sexuality and HIV, in addition to individual barriers such as alcohol use, adverse effects, and concerns about long-term toxicity.

Conclusions: the barriers to PrEP use are multifactorial. Effective interventions are needed to support PrEP users in accessing, complying with, and retaining health services.

Citing Articles

Updates on HIV Pre-exposure Prophylaxis in Latin America: Available Drugs and Implementation Status.

Gonzales-Gavancho C, Araoz-Salinas J, Ramon Tapia R, Quispe-Vicuna C, Reategui-Garcia M, Rios-Garcia W Infez Med. 2025; 33(1):29-49.

PMID: 40071257 PMC: 11892447. DOI: 10.53854/liim-3301-4.

Advancing PrEP for HIV prevention: innovations and the imperative to preserve comprehensive care.

Algarin A, Shrader C BMC Glob Public Health. 2025; 3(1):9.

PMID: 39885612 PMC: 11784111. DOI: 10.1186/s44263-025-00125-1.

Emergency Healthcare Utilization and Unmet Care Needs in Chemsex Users: A Cross-Sectional Survey among Sexual Minority Men.

Gonzalez-Recio P, Moreno-Garcia S, Donat M, Palma D, Guerras J, Belza M J Community Health. 2025; .

PMID: 39833399 DOI: 10.1007/s10900-024-01440-8.

Access of transgender people and transvestites to pre-exposure prophylaxis for HIV in Brazil: a descriptive study, 2018-2023.

Silva A, Pereira I, Alencar T, Kamiensky B, Moura M, Franca F Epidemiol Serv Saude. 2025; 33(spe1):e2024322.

PMID: 39813452 PMC: 11734650. DOI: 10.1590/S2237-96222024v33e2024322.especial.en.

Sociodemographic and clinical follow-up profile of transgender people accessing pre-exposure prophylaxis for the risk of HIV transmission in São Paulo, Brazil (2018-2021).

Silva M, Estevam D, Cardoso M, Nichiata L Epidemiol Serv Saude. 2024; 33(spe1):e2024342.

PMID: 39699388 PMC: 11654812. DOI: 10.1590/S2237-96222024v33e2024342.especial.en.

References

Flexner C, Owen A, Siccardi M, Swindells S . Long-acting drugs and formulations for the treatment and prevention of HIV infection. Int J Antimicrob Agents. 2020; 57(1):106220. PMC: 7790856. DOI: 10.1016/j.ijantimicag.2020.106220. View

Nieto O, Fehrenbacher A, Cabral A, Landrian A, Brooks R . Barriers and motivators to pre-exposure prophylaxis uptake among Black and Latina transgender women in Los Angeles: perspectives of current PrEP users. AIDS Care. 2020; 33(2):244-252. PMC: 7680715. DOI: 10.1080/09540121.2020.1769835. View

Colson P, Franks J, Wu Y, Winterhalter F, Knox J, Ortega H . Adherence to Pre-exposure Prophylaxis in Black Men Who Have Sex with Men and Transgender Women in a Community Setting in Harlem, NY. AIDS Behav. 2020; 24(12):3436-3455. DOI: 10.1007/s10461-020-02901-6. View

Jackson-Gibson M, Ezema A, Orero W, Were I, Ohiomoba R, Mbullo P . Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya. BMC Public Health. 2021; 21(1):1284. PMC: 8252310. DOI: 10.1186/s12889-021-11335-1. View

Vaismoradi M, Turunen H, Bondas T . Content analysis and thematic analysis: Implications for conducting a qualitative descriptive study. Nurs Health Sci. 2013; 15(3):398-405. DOI: 10.1111/nhs.12048. View

de Souza M, Silva M, Carvalho R . Integrative review: what is it? How to do it?. Einstein (Sao Paulo). 2016; 8(1):102-6. DOI: 10.1590/S1679-45082010RW1134. View

Molina J, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I . On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. N Engl J Med. 2015; 373(23):2237-46. DOI: 10.1056/NEJMoa1506273. View

Glidden D, Amico K, Liu A, Hosek S, Anderson P, Buchbinder S . Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension. Clin Infect Dis. 2016; 62(9):1172-7. PMC: 4826449. DOI: 10.1093/cid/ciw022. View

Camp C, Saberi P . Facilitators and barriers of 2-1-1 HIV pre-exposure prophylaxis. PLoS One. 2021; 16(5):e0251917. PMC: 8136636. DOI: 10.1371/journal.pone.0251917. View

10.

Sun C, Anderson K, Bangsberg D, Toevs K, Morrison D, Wells C . Access to HIV Pre-exposure Prophylaxis in Practice Settings: a Qualitative Study of Sexual and Gender Minority Adults' Perspectives. J Gen Intern Med. 2019; 34(4):535-543. PMC: 6445896. DOI: 10.1007/s11606-019-04850-w. View

11.

Hunt T, Lalley-Chareczko L, Daughtridge G, Swyryn M, Koenig H . Challenges to PrEP use and perceptions of urine tenofovir adherence monitoring reported by individuals on PrEP. AIDS Care. 2019; 31(10):1203-1206. DOI: 10.1080/09540121.2019.1587369. View

12.

Stoner M, Rucinski K, Giovenco D, Gill K, Morton J, Bekker L . Trajectories of PrEP Adherence Among Young Women Aged 16 to 25 in Cape Town, South Africa. AIDS Behav. 2021; 25(7):2046-2053. PMC: 8169554. DOI: 10.1007/s10461-020-03134-3. View

13.

Rice W, Stringer K, Sohail M, Crockett K, Atkins G, Kudroff K . Accessing Pre-exposure Prophylaxis (PrEP): Perceptions of Current and Potential PrEP Users in Birmingham, Alabama. AIDS Behav. 2019; 23(11):2966-2979. PMC: 6803068. DOI: 10.1007/s10461-019-02591-9. View

14.

Owens C, Hubach R, Williams D, Voorheis E, Lester J, Reece M . Facilitators and Barriers of Pre-exposure Prophylaxis (PrEP) Uptake Among Rural Men who have Sex with Men Living in the Midwestern U.S. Arch Sex Behav. 2020; 49(6):2179-2191. DOI: 10.1007/s10508-020-01654-6. View

15.

Ogunbajo A, Storholm E, Ober A, Bogart L, Reback C, Flynn R . Multilevel Barriers to HIV PrEP Uptake and Adherence Among Black and Hispanic/Latinx Transgender Women in Southern California. AIDS Behav. 2021; 25(7):2301-2315. PMC: 7845787. DOI: 10.1007/s10461-021-03159-2. View

16.

Wood S, Gross R, Shea J, Bauermeister J, Franklin J, Petsis D . Barriers and Facilitators of PrEP Adherence for Young Men and Transgender Women of Color. AIDS Behav. 2019; 23(10):2719-2729. PMC: 6790163. DOI: 10.1007/s10461-019-02502-y. View

17.

Sack D, De Schacht C, Paulo P, Graves E, Emilio A, Matino A . Pre-exposure prophylaxis use among HIV serodiscordant couples: a qualitative study in Mozambique. Glob Health Action. 2021; 14(1):1940764. PMC: 8266225. DOI: 10.1080/16549716.2021.1940764. View

18.

Ching S, Wong L, Said M, Lim S . Meta-synthesis of Qualitative Research of Pre-exposure Prophylaxis (PrEP) Adherence Among Men Who Have Sex With Men (MSM). AIDS Educ Prev. 2020; 32(5):416-431. DOI: 10.1521/aeap.2020.32.5.416. View

19.

Willie T, Monger M, Nunn A, Kershaw T, Stockman J, Mayer K . "PrEP's just to secure you like insurance": a qualitative study on HIV pre-exposure prophylaxis (PrEP) adherence and retention among black cisgender women in Mississippi. BMC Infect Dis. 2021; 21(1):1102. PMC: 8549215. DOI: 10.1186/s12879-021-06786-1. View

20.

Hojilla J, Vlahov D, Crouch P, Dawson-Rose C, Freeborn K, Carrico A . HIV Pre-exposure Prophylaxis (PrEP) Uptake and Retention Among Men Who Have Sex with Men in a Community-Based Sexual Health Clinic. AIDS Behav. 2017; 22(4):1096-1099. PMC: 5879003. DOI: 10.1007/s10461-017-2009-x. View